Navigation Links
Britain’s cancer initiatives leap forward with a miracle dru

A miracle drug is beginning to light up the lives of thousands of cancer patients, with hope for treating two severe cancers of the kidney and the gut.// Initial examinations of the drug have left a clue of its future use in breast, lung and pancreatic cancers.

This drug called Sutent, nicknamed as the “smart” drug works by nipping an important enzyme that causes the cells to proliferate rapidly, as is the case in some cancers. Further Sutent ensures that tumors run dry of nutrients, thus curbing its growth and development. This is perhaps the first drug of its kind that comprises a dual action.

Paul Nathan, a consultant oncologist at Mount Vernon Cancer Center in Northwood, Northwest London, said: “We have a couple of hundred new kidney cancer patients each year. I’d expect to treat about 50 each year with Sutent. This drug and others like it, we think, are a very major advance in the treatment of this disease.”

Judith Robinson, from the charity GIST Support UK, said: “Sutent is the first drug shown to be effective in patients with advanced GIST where the current standard of care has failed. For patients it can offer precious extra months of life.”

Presently the license for Sutent entails its use in treating kidney cancer and gastrointestinal stromal tumours (GIST). This drug is not easy on the pocket, costing about £2,400 per patient on a monthly basis. There is concern that the high cost of this drug might cause NHS to be careful in its use.
'"/>




Page: 1

Related medicine news :

1. Britain’s Hearts in Good Care – Deaths Due to Heart Disease Falls by 3%
2. Britain’s Mental Health Scene Encouragin
3. Vitamin B12 can help in detecting cancers
4. Want skin cancer? Please have a cigarette
5. New hope for cancer victims – will vaccine cure the deadly bug
6. Clintons new problem - Is the outgoing American president suffering from skin cancer?
7. Are cancer patients being taken for a ride?
8. Breast cancer treatment to be determined by gene test
9. Ductal lavage may detect early breast cancer
10. Beware of the oral patch! It could be cancer!!!
11. New drug helps boost cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... Indianapolis, IN (PRWEB) , ... March 29, 2017 ... ... Benefits Study, this webinar provides insight into the challenges employers face in trying ... the complexity of managing employee benefits programs? Adding to the growing complexity, ...
(Date:3/29/2017)... ... March 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in ... pediatric patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... and experience. When patients receive early treatment, they may achieve straight teeth with less ...
(Date:3/29/2017)... ARNOLD, Md., and MINNETONKA, Minn. (PRWEB) , ... ... ... for the development of medical office buildings (MOBs) and other outpatient facilities, and ... research project to look exclusively at those questions, Revista and Healthcare Real Estate ...
(Date:3/29/2017)... MD (PRWEB) , ... March 29, 2017 , ... ... is proud to announce the finalization of the company’s executive management team with prominent ... and leading operations is Curio Wellness’ Chief Operating Officer, Ted Dumbauld , who ...
(Date:3/29/2017)... ... , ... HealthCareMandA.com will host an important webinar — Home Health & Hospice: ... recording of the webinar will also be made available following its live presentation. The ... are still popular targets for healthcare investors. This highly fragmented sector bounced back in ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017  Designers of primary cell wearable medical and ... 50% and extend battery life with the MAX20310 ultra-low ... (PMIC) from Maxim Integrated Products, Inc. (NASDAQ: ... voltage of just 0.7V for new high-energy density battery ... well as the more common Alkaline battery architecture. With ...
(Date:3/29/2017)... , March 29, 2017  NuVasive, Inc. (NASDAQ: ... transforming spine surgery with minimally disruptive, procedurally-integrated solutions, ... 510(k) clearance of the CoRoent® Small Interbody™ System ... levels in the cervical spine. This marks the ... be used at up to four contiguous levels. ...
(Date:3/29/2017)... Utah , March 29, 2017   ... announced today the appointment of Cynthia L. ... Cyndi will be responsible for leading Dynatronics manufacturing, ... and will report to Dynatronics, CEO Kelvyn ... appointment concludes an extensive search process conducted by ...
Breaking Medicine Technology: